Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
7.35
Dollar change
+0.25
Percentage change
3.52
%
Index- P/E- EPS (ttm)-0.62 Insider Own0.54% Shs Outstand36.91M Perf Week-0.68%
Market Cap271.44M Forward P/E- EPS next Y-0.27 Insider Trans0.00% Shs Float36.73M Perf Month27.60%
Income-22.87M PEG- EPS next Q-0.11 Inst Own43.32% Short Float0.31% Perf Quarter40.40%
Sales65.27M P/S4.16 EPS this Y41.24% Inst Trans29.56% Short Ratio2.74 Perf Half Y15.93%
Book/sh1.87 P/B3.94 EPS next Y26.33% ROA-21.88% Short Interest0.11M Perf Year-34.49%
Cash/sh1.30 P/C5.65 EPS next 5Y3.00% ROE-32.82% 52W Range3.60 - 12.23 Perf YTD39.20%
Dividend Est.- P/FCF- EPS past 5Y-113.97% ROI-34.37% 52W High-39.90% Beta0.74
Dividend TTM- Quick Ratio2.30 Sales past 5Y7.38% Gross Margin40.39% 52W Low104.17% ATR (14)0.33
Dividend Ex-Date- Current Ratio2.84 EPS Y/Y TTM-715.57% Oper. Margin-32.81% RSI (14)56.53 Volatility3.04% 4.93%
Employees264 Debt/Eq0.10 Sales Y/Y TTM11.61% Profit Margin-35.03% Recom1.00 Target Price10.36
Option/ShortYes / Yes LT Debt/Eq0.06 EPS Q/Q-0.07% Payout- Rel Volume1.42 Prev Close7.10
Sales Surprise7.75% EPS Surprise-241.89% Sales Q/Q27.70% EarningsMar 27 BMO Avg Volume41.03K Price7.35
SMA20-0.23% SMA5010.13% SMA2006.52% Trades Volume58,411 Change3.52%
Date Action Analyst Rating Change Price Target Change
Nov-01-22Initiated Jefferies Buy $11
Apr-28-21Initiated Piper Sandler Overweight $13
Apr-15-20Initiated B. Riley FBR Buy $5.50
Jul-28-14Downgrade Northland Capital Outperform → Market Perform $6 → $3.50
Jun-16-14Initiated H.C. Wainwright Buy $6
Mar-05-13Initiated Northland Capital Outperform $6
Nov-18-10Reiterated Morgan Joseph Buy $3 → $5.25
Aug-20-09Reiterated Roth Capital Hold $2.50 → $5
Nov-24-08Reiterated Roth Capital Hold $2.50
Mar-26-08Reiterated Roth Capital Hold $6 → $4.50
Mar-27-24 11:53AM
07:00AM
Mar-13-24 07:00AM
Mar-06-24 07:00AM
Mar-04-24 07:00AM
07:00AM Loading…
Feb-29-24 07:00AM
Feb-01-24 08:00AM
Jan-08-24 08:00AM
Jan-02-24 08:00AM
Dec-12-23 08:00AM
Dec-06-23 04:30PM
Nov-30-23 08:00AM
Nov-20-23 08:00AM
Nov-10-23 03:33PM
Nov-09-23 06:00AM
08:00AM Loading…
Nov-06-23 08:00AM
Oct-26-23 08:00AM
Sep-06-23 08:00AM
Aug-25-23 09:06AM
Aug-24-23 06:30AM
Aug-10-23 08:00AM
Jul-26-23 08:00AM
Jul-06-23 11:05AM
Jun-09-23 10:37AM
May-24-23 08:00AM
May-17-23 06:30AM
May-05-23 01:33PM
May-03-23 08:00AM
Apr-21-23 08:00AM
Apr-10-23 08:00AM
08:00AM Loading…
Apr-06-23 08:00AM
Apr-05-23 07:44PM
Mar-30-23 06:30AM
Mar-24-23 06:30AM
Mar-21-23 04:30PM
Mar-10-23 08:12AM
Mar-09-23 08:00AM
Feb-14-23 09:00AM
Jan-31-23 08:00AM
Jan-21-23 09:29AM
Jan-05-23 08:00AM
Dec-31-22 09:03AM
Dec-23-22 11:43PM
Dec-10-22 08:17AM
Dec-06-22 08:00AM
Nov-30-22 04:01PM
08:50AM
Nov-22-22 08:42AM
Nov-21-22 10:00AM
08:00AM
07:10AM
Nov-16-22 04:35PM
Nov-15-22 09:40AM
Nov-14-22 08:36AM
Nov-10-22 08:50AM
Nov-03-22 06:07AM
Nov-02-22 08:00AM
Nov-01-22 05:22PM
Oct-27-22 09:40AM
Oct-24-22 08:50AM
Oct-11-22 09:40AM
Sep-27-22 02:33PM
Sep-26-22 08:00AM
Sep-22-22 08:54PM
04:01PM
Aug-30-22 09:40AM
08:50AM
Aug-25-22 08:47AM
Aug-24-22 04:35PM
Aug-03-22 08:00AM
Aug-01-22 08:50AM
Jul-28-22 09:40AM
Jul-19-22 08:24AM
06:17AM
Jul-18-22 07:00AM
Jul-12-22 09:40AM
Jun-28-22 09:00AM
Jun-14-22 08:00AM
Jun-06-22 08:00AM
May-17-22 04:35PM
May-10-22 08:30AM
May-05-22 08:30AM
Apr-12-22 08:00AM
Mar-30-22 04:35PM
Mar-21-22 08:00AM
Mar-17-22 08:20AM
Feb-09-22 05:19AM
Feb-01-22 08:00AM
Jan-13-22 08:00AM
Jan-05-22 08:00AM
Jan-04-22 05:32AM
Nov-29-21 09:30AM
Nov-20-21 07:29AM
Nov-17-21 04:35PM
Nov-10-21 08:00AM
Sep-29-21 03:26PM
Sep-28-21 08:00AM
Sep-14-21 08:00AM
Sep-07-21 04:35PM
Aug-25-21 04:35PM
EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.